Neurogene

Neurogene, Inc. was founded in January 2018 with the aim of providing novel drugs for individuals suffering from rare neurological disorders. The company collaborates with academic researchers, patient advocacy organizations, and caregivers to offer patients innovative gene therapies that address the underlying genetic causes of neurological conditions currently lacking effective treatment options.